IL17B and neoplasm: The results showed that rIL-17B promoted tumor growth in a concentration-dependent manner (Fig. 3A, B); with an increasing concentration of IL-17B, the tumorigenicity of the cells occurred earlier, and all tumors developed earlier in the mice (Fig. 3C).